期刊文献+

靶向bcl-2基因转录shRNA重组质粒的构建和筛选 被引量:1

下载PDF
导出
摘要 目的构建能高效抑制肝星状细胞(HSCs)bcl-2表达的小发夹RNA(shRNA)重组质粒。方法利用RNA干扰技术,设计有小发夹结构的3条DNA序列,经退火形成互补双链,克隆至转录载体psiRNA-hH1neo上构建重组质粒,予以酶切和测序鉴定。重组质粒转染HSC-T6细胞株,运用实时荧光定量PCR和Western blotting进行筛选鉴定。结果酶切及测序鉴定表明,成功构建重组质粒shRNA1、shRNA2和shRNA3。实时荧光定量PCR和Western blotting检测结果显示,shRNA1和shRNA2转染后显著抑制HSC-T6中bcl-2mRNA和蛋白表达(P<0.05),其中siRNA1的bcl-2表达抑制效率>80%。结论构建的重组质粒shRNA1能有效抑制HSCs中bcl-2的表达。实验为进一步探索肝纤维化基因治疗的新途径奠定了基础。
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2008年第2期224-227,共4页 Journal of Shanghai Jiao tong University:Medical Science
  • 相关文献

参考文献8

  • 1Novo E, Marra F, Zamara E,et al. Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans[J]. Gut,2006,55(8) :1174 - 1182.
  • 2Mutluay R, Ozenirler S, Poyraz A. The expression of bcl-2 in chronic liver diseases[J].Saudi Med J,9005,26(8) :1245 -1249.
  • 3Zhou D, He QS, Wang C, et al. RNA interference and potential applications[J]. Curr Top Med Chem,2006,6 (9) :901 - 911.
  • 4Arocho A, Chen B, Ladanyi M,et al. Validation of the 2-Deha- DeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P'210 transcripts[J]. Diagn Mol Pathol, 2006, 15(1) :56 -61.
  • 5Song E, Lee SK, Wang J, et al. RNA interference targeting Fas protects mice from fulminant hepatitis [ J ]. Nat Med, 2003,9 ( 3 ) : 347 - 351.
  • 6Kawada N. Human hepatic stellate cells are resistant to apoptosis : implications for human flbrogenic liver disease[J].Gut, 2006,55 (8) : 1073 -1074.
  • 7Fu GF, Lin XH, Han QW,et al. RNA interference remarkably suppresses bcl-2 gene expression in cancer cells in vitro and in vivo [J]. Cancer Biol Ther,2005,4 (8) :822 - 829.
  • 8Nicholson DW. From bench to climic with apoptosis-based therapeutic agentsEJ~. Nature, 2000, 407(6805) :810 -816.

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部